Epizyme, Inc. is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. EPZM has around 7.3M shares in the U.S. ETF market. The largest ETF holder of EPZM is the iShares Russell 2000 ETF (IWM), with approximately 1.76M shares. Investors may also find of interest that the ETF with the largest allocation to EPZM stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 1.41%. On average, U.S. ETFs allocate 0.17% of EPZM to their portfolios.
Additionally, EPZM is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EPZM as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.